Researchers from the Johns Hopkins Kimmel Cancer Center have created a blood test that can predict the risk of breast cancer recurrence and monitor the disease's response to treatment, according to recently published findings in the journal Cancer Research.
Print All Daily Briefing Article from
04/17/2014
Share:
Have a Question?
x
Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.
